CITIC unit has held talks on its stake in Singapore's Biosensors
HONG KONG Feb 19 (Reuters) - CITIC Private Equity Funds Management has held talks on its stake in Biosensors International Group Limited, the medical equipment maker said on Wednesday following a report that CITIC was considering a full buyout of the company.
Bloomberg reported on Tuesday that the CITIC Group unit was planning to take full control and has held talks with banks about financing a buyout.
China's CITIC bought its 21.7 percent stake in Singapore-listed Biosensors last November. The company, valued at around S$1.8 billion ($1.4 billion) makes drug-eluting stents and other medical devices. It has its headquarters in Morges, Switzerland and manufacturing operations in Singapore.
The buyout firm has held "very preliminary discussions" to explore options relating to its stake, but no decision has been made to pursue any option, Biosensors said.
Biosensors' stock was down 1 percent on Wednesday at S$0.98 after ending 14 percent higher a day earlier on the Bloomberg report.
- U.S. and Arab allies launch first strikes on fighters in Syria |
- D'Souza gets community confinement for election law violation
- Three killed, including shooter, at UPS facility in Alabama
- Israel downs Syrian warplane it says violated its Golan airspace
- Argentina's Fernandez to meet billionaire investor Soros in New York